BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 680704)

  • 1. GLO I and Bf phenotype distribution in a West German population sample.
    Mauff G; Wachauf P; Schaal KP; Pulverer G
    Hum Hered; 1978; 28(6):431-4. PubMed ID: 680704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell glyoxalase I polymorphism in Alsace, France: linkage of GLO with Bf.
    North ML; Amann I; Tongio MM; Hauptmann G; Klein J; Mayer S
    Hum Hered; 1981; 31(1):39-41. PubMed ID: 6910464
    [No Abstract]   [Full Text] [Related]  

  • 3. No evidence for linkage disequilibrium between Bf and GLO in African negroids.
    Bender K; Mauff G; Hitzeroth HW
    Hum Genet; 1977 Sep; 38(2):227-30. PubMed ID: 908570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic susceptibility to diabetes mellitus: the distribution of properdin factor B (Bf) and glyoxalase (GLO) phenotypes.
    Kirk RL; Theophilus J; Whitehouse S; Court J; Zimmet P
    Diabetes; 1979 Oct; 28(10):949-51. PubMed ID: 478186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 1. Recombination frequencies.
    Kömpf J; Bissbort S; Göhler F; Schunter F; Wernet P
    Hum Genet; 1978 Nov; 44(3):313-9. PubMed ID: 730169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of properdin factor B and glyoxalase I (further genetic markers) in Northern Ireland.
    Hamilton P; Middleton D
    Ulster Med J; 1988 Apr; 57(1):41-4. PubMed ID: 3166548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 2. Segregation analysis.
    Schunter F; Wernet P; Kömpf J; Bissbort S; Göhler F
    Hum Genet; 1978 Nov; 44(3):321-31. PubMed ID: 730170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the population genetics of the red cell glyoxalase I (GLO).
    Stöhlmacher P; Haferland W
    Hum Genet; 1977 Dec; 39(3):303-4. PubMed ID: 598837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: confirmation of an increase of BF*FT.
    Tokunaga K; Omoto K; Juji T; Itoh T
    Hum Genet; 1982; 62(1):86-8. PubMed ID: 6924917
    [No Abstract]   [Full Text] [Related]  

  • 10. Properdin factor Bf polymorphism and glyoxase I allotypes in Graves' disease.
    Wenzel KW; Wenzel BE; Weise W
    Tissue Antigens; 1981 Feb; 17(2):247-8. PubMed ID: 6908967
    [No Abstract]   [Full Text] [Related]  

  • 11. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
    Regueiro JR; Arnaiz-Villena A
    Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLO polymorphism in Polish population.
    Schlesinger D; Hałasa J; Mańczak M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):173-6. PubMed ID: 749767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic factors Bf and glyoxalase in Basedow's disease].
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Guéguen M; Dinh KT; Le Gall JY; Genétet B
    Rev Med Interne; 1982 Jun; 3(2):129-32. PubMed ID: 6924395
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigations on the polymorphism of glyoxalase I (EC 4.4.1.5) in the population of Hessen, Germany.
    Kühnl P; Schwabenland R; Spielmann W
    Hum Genet; 1977 Aug; 38(1):99-106. PubMed ID: 409660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Population-genetic examination of the glyoxalase I (GLO) red-cell isoenzyme system in the inhabitants of Szeged and its environment (South-Hungary) (author's transl)].
    Kósa F; Fekete-Csete K; Földes V
    Z Rechtsmed; 1982; 88(1-2):113-9. PubMed ID: 7080674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics.
    Kirk RL; Ranford PR; Serjeantson SW; Thompson AR; Munirathnam Chetty SM; John L; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
    Diabetes Res Clin Pract; 1985 Mar; 1(1):41-7. PubMed ID: 3879724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLO polymorphism in Iceland.
    Karlsson S; Arnason A; Jensson O
    Hum Hered; 1980; 30(6):383-5. PubMed ID: 7216230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of GPT and GLO-I in Galicia (northwest Spain): a comparative study.
    Caeiro JL; Carracedo A; Boán F
    Anthropol Anz; 1987 Mar; 45(1):63-70. PubMed ID: 3579235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properdin factor B (Bf) and glyoxalase in Graves' disease.
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Gueguen M; Knoi TD; Genetet B; Le Gall JY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):57-61. PubMed ID: 6572032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glyoxalase I polymorphisms: distribution of phenotypes and gene frequencies in Portugal (author's transl)].
    Weissmann J; Pribilla O
    Z Rechtsmed; 1981; 86(3):205-11. PubMed ID: 7234136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.